Deutsch | English | Français - CHF | EUR | USD
Analysen | Arzt | Interaktionen | Medikamente | MiGeL | Services | Spital | Zulassungsinhaber
 Sie befinden sich in - ATC-Browser - Fachinformation zu Flutinase® Polynex
Fachinformation zu Flutinase® Polynex:GlaxoSmithKline AG
Vollst. FachinformationDDDDrucken 
Zusammens.Galen.FormInd./Anw.mögl.Dos./Anw.Kontraind.Warn.hinw.Interakt.Schwangerschaft
Fahrtücht.Unerw.WirkungenÜberdos.Eigensch.Pharm.kinetikPräklin.Sonstige H.Swissmedic-Nr.
PackungenReg.InhaberStand d. Info.
R01AD08 - FluticasoneATC-DDD Version 2012. Source: WHO
R - Respiratory System

Inhaled antiinfectives are classified in ATC group J - Antiinfectives for systemic use.

R01 - Nasal Preparations
 
R01A - Decongestants and Other Nasal Preparations for Topical Use

This group comprises preparations for local treatment in nasal congestion (e.g. sympathomimetics) or for prophylaxis and treatment of allergic rhinitis (e.g. corticosteroids, cromoglicate preparations). Most of the products are nasal drops, nasal sprays or nasal inhalants.
See also R01B - Nasal decongestants for systemic use, and R06 - Antihistamines for systemic use.

The DDDs are based on treatment of both nostrils.

R01AD - Corticosteroids

Combinations of corticosteroids and antiinfectives, sympathomimetics etc. should be classified in this group at separate 5th levels by using the 50-series.
Fluticasone propionate is classified in R01AD08.

The DDDs are mainly based on the starting dose in the treatment of rhinitis.

R01AD08 - Fluticasone
StärkeAdm.RouteNote
0.2 mgN 
LGPL2013 ywesee.com, Commit-ID
Einstellungen | Hilfe | FAQ | Anmeldung | Kontakt | Home